Information, insights, and advice for ACS industry members
March 25, 2020
As Alexa Dembek, DuPont’s Chief Technology and Sustainability Officer put it, “… we have not faced a crisis as multifaceted as COVID-19 in generations.” Indeed. Which is why we asked executives in several industries to let us know what they have learned so far about moving their businesses forward in the face of such an overwhelming, complex, and dynamic challenge.

My thanks to Alexa Dembek, DSM’s Marcus Remmers, Pfizer’s Charlotte Allerton, ExxonMobil’s Vijay Swarup, and Genentech’s Wendy Young for escaping the crucible long enough to share their thoughts with ACS Industry Matters readers.
John C. Katz
Executive Editor
Presumably there is no playbook on your bookshelf labeled, “Open in case of Global Pandemic.” What have you learned to-date about moving your business forward in the face of an exceptionally disruptive ‘black swan’ event?
Marcus Remmers, Chief Technology Officer, DSM
Chief Technology Officer,
"First and foremost, your employees’ well-being should be..." Read More
"In the face of this unprecedented healthcare challenge, the well-being of our colleagues, their families and... " Read More
Charlotte Allerton, Head of Medicine Design, Pfizer
Head of Medicine Design,
Vijay Swarup, Vice President of Research and Development, ExxonMobil
Vijay Swarup
Vice President of Research and Development,
"The quick rise and spread of COVID-19 around the globe had shown us just how interconnected we have become as..." Read More
"During any crisis – I have a motto: put people first. It is..." Read More
Alexa Dembek, Chief Technology and Sustainability Officer, DuPont
Chief Technology and Sustainability Officer,
Wendy Youmg, Vice President of Small Molecule Drug Discovery, Genentech
Senior Vice President of Small Molecule Drug Discovery,
"One of the most important things we’ve learned is something we already knew..." Read More
A special Women's History Month edition of ACS Industry Matters: the most popular articles featuring female chemists from past newsletters
C&EN Free COVID-19 Coverage
At the end of Dec. 2019, scientists discovered a novel coronavirus infecting people in Wuhan, China. On March 11, the World Health Organization declared that COVID-19, the respiratory disease caused by the novel coronavirus SARS-CoV-2, is a pandemic. C&EN has made free its coverage of the race to understand and respond to COVID-19. Read More
Chemistry in Coronavirus Research: A Free to Read Collection from the American Chemical Society
In light of the current outbreak of a novel coronavirus (2019–nCoV), ACS Publications would like to share this Virtual Issue that features a collection of articles on coronavirus research. Chemistry has a key role to play in understanding everything from viral structure to pathogenesis, isolation of vaccines and therapies, as well as in the development of materials and techniques used by basic researchers, virologists and clinicians. Read the Free ACS Publication
ACS Webinars: How You Can Improve Global Public Health
Across the globe, millions of people are at an increased risk of illness or death due to poor quality control for medicines, dietary supplements, and foods. A strong set of standards and guidelines is needed to ensure their consistent quality. The U.S. Pharmacopeia (USP) establishes quality standards and sets the bar for scientific rigor and technological progress, and they are looking for your assistance. Learn More